INOmax Evolve DS Nitric Oxide Delivery System
Mallinckrodt’s INOmax Evolve DS features automated backup delivery and improved portability for infants in the neonatal intensive care unit.
Tag: INOmax inhaled nitric oxide
All
Latest
INOmax Evolve DS Nitric Oxide Delivery System
Mallinckrodt’s INOmax Evolve DS features automated backup delivery and improved portability for infants in the neonatal intensive care unit.
Read More
Innovations in Inhaled Nitric Oxide Delivery
In this edition of our “Industry Analysis” series, RT magazine speaks with manufacturers of inhaled nitric oxide delivery systems about the latest market innovations in the iNO industry.
Read More
Wisconsin Hospital Becomes First to Implement New Nitric Oxide Delivery System
The hospital is using the INOmax Evolve DS system, a nitric oxide delivery device used with mechanical ventilation for critically ill patients.
Read More
Mallinckrodt Expands Rollout of INOmax Evolve DS
Mallinckrodt has begun a national rollout of the INOmax Evolve DS delivery system, which is FDA-cleared to provide inhaled nitric oxide to certain neonatal ICU patients in order to improve oxygenation and reduce the need for extracorporeal membrane oxygenation.
Read More
FDA Clears INOmax Evolve DS
The INOmax Evolve DS is Mallinckrodt’s next-generation nitric oxide delivery system that includes a primary delivery system, a monitoring system, an electronic blender, automated backup delivery, mini-cylinders, and more.
Read More
Mallinckrodt Submits iNO Delivery System for FDA Clearance
Mallinckrodt plc reports the submission of a 510(k) premarket notification application to the US FDA for an investigational inhaled nitric oxide delivery system for INOmax (nitric oxide) gas, for inhalation.
Read More
Study Evaluates Inhaled Nitric Oxide for COVID-19
Researchers assessed outcomes of INOmax inhaled nitric oxide for COVID-19 patients hospitalized with mild-to-moderate ARDS.
Read More